Aditxt, Inc. (ADTX)
NASDAQ·Healthcare·Biotechnology
$0.22
-11.77%
Mkt Cap $9.33K
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$160.00
Range $160.00 – $160.00
Implied Upside
+72726.6%
Consensus $160.00 vs current $0.22
NASDAQ·Healthcare·Biotechnology
$0.22
-11.77%
Mkt Cap $9.33K
No recent rating data.
Price Target (1 analysts)
$160.00
Range $160.00 – $160.00
+72726.6%
Consensus $160.00 vs current $0.22